AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$INFU

InfuSystem Holdings, Inc

Price · $INFUvia TradingView
AI sentiment · 7d1 articles
MAY 20net (bullish − bearish)MAY 26
Bullish
1
Neutral
0
Bearish
0
Insider · 30dFeed →

No SEC Form 4 filings for $INFU in the last 30 days.

Top stories · $INFUMore →
MAY 21·The Globe and MailHigh

Analysts Offer Insights on Healthcare Companies: InfuSystem Holdings (INFU) and BioMarin Pharmaceutical (BMRN)

Healthcare analysts have provided optimistic insights on InfuSystem Holdings (INFU) and BioMarin Pharmaceutical (BMRN). Craig-Hallum maintained a Buy rating on InfuSystem Holdings with a significant upside, while J.P. Morgan initiated coverage on BioMarin Pharmaceutical with a Buy rating and a set price target. Both companies show strong analyst consensus ratings.

MAY 15·Stock Titan

InfuSystem Holdings (INFU) EVP & CIO receives RSUs, options and updates share holdings

InfuSystem Holdings, Inc.'s EVP and CIO, Addam Chupa, reported an update to his shareholdings and new equity awards, including 47,210 directly held common shares. He received 9,973 restricted stock units (RSUs) and 20,777 stock options with an exercise price of $8.37 per share. Both the RSUs and stock options begin vesting in equal annual installments starting May 12, 2027.

MAY 15·Stock Titan

InfuSystem Holdings (INFU) director granted options on 24,890 shares

InfuSystem Holdings director Beverly A. Huss reported receiving a stock option grant for 24,890 shares, with an exercise price of $8.37 per share. The options will vest on May 12, 2027, and expire on May 12, 2036. This grant represents compensation and not an open-market transaction, adding to her direct holding of 4,300 common shares.

News on $INFU

All news →